TGF-β1 gene mutations in insulin-dependent diabetes mellitus and diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 9, Issue 12, 1998, Pages 2302-2307

  Pociot, Flemming ^a   Hansen, Pernille Mørk ^a   Karlsen, Allan E ^a   Langdahl, Bente L ^b   Johannesen, Jesper ^a   Nerup, Jørn ^a  

^a STENO DIABETES CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; ISOLEUCINE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; THREONINE; THYMINE; TRANSFORMING GROWTH FACTOR BETA1; COMPLEMENTARY DNA; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC REGULATION; GENOTYPE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; BIOSYNTHESIS; COMPARATIVE STUDY; DENMARK; DRUG EFFECT; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; INTRON; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION;

AMINO ACID SUBSTITUTION; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENOTYPE; INTRONS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE DELETION; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031593542     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Roberts AB, Sporn MB: The transforming growth factor-βs. In: Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors I, Vol., 95, edited by Sporn MB, Roberts AB, Berlin, Springer Verlag, 1990, pp 419-472
2. Wahl SM: Transforming growth factor β: The good, the bad, and the ugly. J Exp Med 180: 1587-1590, 1994
3. Lawrence DA: Transforming growth factor-β: A general review. Eur Cytokine Netw 7: 363-374, 1996
4. Sellheyer K, Bickenbach JR, Rothnagel JA, Bundman D, Long-ley MA, Krieg T, Roche NS, Roberts AB, Roop DR: Inhibition of skin development by overexpression of transforming growth factor-β1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90: 5237-5241, 1993
5. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699, 1992
6. Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor β null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770-774, 1993
7. Santambrogio L, Hochwald GM, Saxena B, Leu C-H, Martz JE, Carlino JA, Ruddle NH, Palladino MA, Gold LI, Thorbecke GJ: Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J Immunol 151: 1116-1127, 1993
8. Schattner A: Lymphokines in autoimmunity: A critical review. Clin Immunol Immunopathol 70: 177-189, 1994
9. Dang H, Geiser AG, Letterio JJ, Nakabayashi T, Kong L, Fernandes G, Talal N: SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-β knockout mice. J Immunol 155: 3205-3212, 1995
10. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 266: F829-F842, 1994
11. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994
12. Bruijn JA, Roos A, Geus BD, Heer ED: Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123: 34-47, 1994
13. Steffes MW, Østerby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081, 1989
14. Yamamoto T, Nakamura TM, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90: 1814-1818, 1993
15. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42: 450-456, 1993
16. Shankland S, Scholey J: Expression of transforming growth-factor-beta-1 during diabetic renal hypertrophy. Kidney Int 46: 430-442, 1994
17. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGFβ-antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
18. Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H: Quantification of glomerular TFG-β1 mRNA in patients with diabetes mellitus. Kidney Int 49: 1120-1126, 1996
19. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BRC, Kurnik PB, Weisberg LS: Increased renal production of transforming growth factor-β1 in patients with type II diabetes. Diabetes 46: 854-859, 1997
20. Yokoyama H, Deckert T: Central role of TGF-β in the pathogenesis of diabetic nephropathy and macrovascular complications: A hypothesis. Diabetic Med 13: 313-320, 1996
21. Border W, Yamamoto T, Noble N: Transforming growth-factor-beta in diabetic nephropathy. Diabetes Metab Rev 12: 309-339, 1996
22. Langdahl B, Knudsen J, Jensen H, Gregersen N, Eriksen E: A sequence variation - 713-8delc in the transforming growth-factor-beta-1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very-low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20: 289-294, 1997
23. Mitlianga P, Germanidis G, Moutsopoulos HM, Papadopoulos GK: The effect of transforming growth factor beta-1, and tumor necrosis factor alpha on the cytotoxic-cytostatic action of interleukin-1 (alpha isoforms and beta isoforms) on the pancreatic b-cell line rin-5ah. Int J Immunopathol Pharmacol 8: 67-77, 1995
24. Derynck R, Rhee L, Chen EY, Tilburg AV: Intron-exon structure of the human transforming growth factor-β precurser gene. Nucleic Acids Res 15: 3188-3189, 1987
25. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988
26. Rust S, Funke H, Assmann G: Mutagenically separated PCR (MS-PCR): A highly specific one-step procedure for easy mutation detection. Nucleic Acids Res 21: 3623-3629, 1993
27. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T: Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes 36: 205-209, 1987
28. Forsblom CM, Groop P-H, Ekstrand A, Groop LC: Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long-term duration. Br Med J 305: 1051-1053, 1992
29. Spector T, Chiano M, Shieder H, Heathcote K, Kemp P, Carter N, Grainger D: The genetics of transforming growth factor type β. Am J Hum Genet 61: A295, 1997
30. Krawezak M, Reiss J, Cooper DN: The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum Genet 90: 41-54, 1992